2007 Annual Meeting | Update in Neuroimaging: Essentials and BeyondPart II

Date Saturday 05/05/07

Time 09:00 AM - 12:45 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type AM Half-Day Course

Director(s) John B. Chawluk, MD, FAAN

Topic(s)

Learning Objectives Participants should be able to understand how neuroimaging studies are used to diagnose dementia and enhance the treatment of patients with dementing illnesses; know when to order scans in a headache evaluation and which imaging modalities will be most diagnostically and economically effective; understand the technical basis of MR spectroscopy, functional neuroimaging modalities, and ultrasound; know how these technologies are useful in the study and management of neurological patients; and expertly manage stroke patients with appropriate neuroimaging studies.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Resident, Nurse, Other

Event Timeline
09:00 AM - 09:30 AM		Neuroimaging of Dementia Michael Hutchinson, MD, PhD
09:30 AM - 10:00 AM		Neuroimaging of Headache John B. Chawluk, MD, FAAN
10:00 AM - 10:30 AM		MR Spectroscopy Brian D. Ross, MD
10:30 AM - 10:45 AM		Break
10:45 AM - 11:15 AM		Neuroimaging of Stroke Lawrence R. Wechsler, MD, FAAN
11:15 AM - 11:45 AM		Angiographic Techniques Hamza I. Maqsood, MD
11:45 AM - 12:15 PM		Functional Neuroimaging Joseph C. Masdeu, MD, PhD, FAAN
12:15 PM - 12:45 PM		Neurosonology Charles H. Tegeler, MD

Faculty Disclosures
John B. Chawluk, MD, FAAN	No disclosure on file
Joseph C. Masdeu, MD, PhD, FAAN	Dr. Masdeu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Moody Foundation. The institution of Dr. Masdeu has received research support from Biogen. The institution of Dr. Masdeu has received research support from Eli Lilly. The institution of Dr. Masdeu has received research support from Eisai. The institution of Dr. Masdeu has received research support from Novartis. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE.
Charles H. Tegeler, MD	Dr. Tegeler has nothing to disclose.
Lawrence R. Wechsler, MD, FAAN	Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Wechsler has stock in Forest Devices.
Michael Hutchinson, MD, PhD	No disclosure on file
Brian D. Ross, MD	No disclosure on file
Hamza I. Maqsood, MD	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.

��ɫ��

��ɫ��